To further validate this promising target identified in our screen, we first confirmed that different shRNAs and an siRNA pool targeting YAP1 can efficiently knockdown YAP1 protein expression in the PC9 lung cancer cell line (Figure 2A and 2B). The gene discussed is YAP1; the disease is lung carcinoma.